Gara Jalqabaatti › Luukemiya Mayiloodii Faasii Keessummaa › Alabama
Qorannoo klinikaalii Luukemiya Mayiloodii Faasii Keessummaa Alabama keessatti
Qorannoo 3 Luukemiya Mayiloodii Faasii Keessummaa f Alabama keessatti hirmaatuu jiru.
Magaalota Alabama keessatti
Takkalaa qorannoo (Ingiliffa)
Study of Olverembatinib (HQP1351) in Patients With CML-CP
- Ascentage Investigative Site #1044, Birmingham
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT06423911A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
- University of Alabama at Birmingham, Birmingham
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 20-Ado-2026 · NCT07091019A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
- University of Alabama Medicine (UAB Medicine), Birmingham
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 12-Ama-2026 · NCT06163430Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.